Search
Intellia Therapeutics Inc
NTLAAdd to Watchlist
10.680USD
-0.410-3.70%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.49BMarket Cap
LossP/E TTM
Intellia Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Intellia Therapeutics Inc is 5.96, ranking 352 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.04, which is -60.48% below the recent high of -1.20 and -182.12% above the recent low of -8.57.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.